Oncology Therapy Access in the Era of Personalized Medicine

43 Pages

Focusing on selected Middle East and Africa countries, this report evaluates regulatory approval, reimbursement timelines, and access to innovative oncology therapies. It highlights significant variation in registration rates, time to reimbursement, and public funding across countries. The analysis emphasizes challenges related to precision medicines, companion diagnostics, and health system readiness. The report outlines policy actions and collaboration strategies needed to improve equitable access to advanced cancer therapies.

Join for free to read

Case Study Driving Oncology Engagement in the Era of Precision Medicine

Ebook Pathology in the Era of Precision Medicine

Case Study Medical Affairs 2025 Excellence in the Era of Precision Medicine

Report A new era of precision medicine

More from IQVIA

White Paper Radioligand Therapy as the Future of Cancer Care in Singapore

White Paper Digital Twins in Healthcare: Unlocking the Future of…

Report Global Medicine Spending and Usage Trends

Report Global Oncology Trends 2022

Report

Oncology Therapy Access in the Era of Personalized Medicine

Oncology Therapy Access in the Era of Personalized Medicine

You Might Also Like

More from IQVIA